The effects of walking exercise on glycometabolism, dynamic blood pressure and the quality of life of patients with hypertension and type 2 diabetes
10.3760/cma.j.issn.0254-1424.2014.08.010
- VernacularTitle:步行运动对高血压合并糖尿病患者糖代谢、动态血压及生活质量的影响
- Author:
Zhengbin WANG
;
Chunguang QIU
;
Zhenwen HUANG
;
Zhanying HAN
;
Guoju SUN
;
Han SUN
- Publication Type:Journal Article
- Keywords:
Walking exercise;
Hypertension;
Diabetes;
Glucose metabolism;
Blood pressure;
Quality of life
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2014;36(8):609-613
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of walking exercise on glycometabolism,dynamic blood pressure and the quality of life of patients with both hypertension and type 2 diabetes on the basis of conventional drug treatment.Methods Sixty-two patients with both hypertension and diabetes who could support taking walking exercise of more than 5,000 steps/d were randomly divided into a walking exercise group (32 cases) and a control group (30 cases).Both groups were given conventional drug treatment (including valsartan,acarbose and metformin).Those in the walking exercise group took more than 10,000 steps/d of aerobic exercise while the patients in the control group were just given normal community care.This continued for a period of 3 months.Fasting plasma glucose (FPG),glycated hemoglobin-A1C (HbA1c),fasting insulin (FINS),the homeostasis model of assessment for insulin resistence index (HOMA-IR),the homeostasis model of assessment for insulin sensitivity (HOMA-IS),dynamic blood pressure parameters and quality of life were observed.Results In the walking exercise group,the FPG,HbA1c,FINS,HOMA-IR,HOMA-IS,dynamic blood pressure and quality of life indicators were all significantly different after 3 months of daily walking exercise compared with either baseline or the control group.Conclusion Accompanied by conventional drug therapy,10,000 steps/d of walking exercise can improve the glucose metabolism,dynamic blood pressure and quality of life of patients suffering from mild hypertension and type 2 diabetes.
